Clinical Trial Update: Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenvatinib for metastatic or advanced pheochromocytoma or paraganglioma that cannot be surgically removed; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma | Phase 2 | Status: COMPLETED | Results posted: 2021-05-14